Clinical Application of Little Dose Defibrinogenase to Angina Pectoris
Chunmin Tao
Abstract
Chunmin Tao
Abstract
Objective To observe the effect and safety of little dose defibrinogenase on patients with angina pectoris. Methods Forty cases received the little dose deribrinogenase by intravenous drips, other forty-six cases were control group. In order to judge the efficacy and safety of defibrinogenase, angina pectoris, ECG, live function, renal function and coagulation were observed in two groups. Results The total effective rate in treatment group was 82.50%, but in control group was 63.04%, there was significantly different (P0.01), and it had no side effect on live and renal function. Conclusions Little dose defibrinogenase is effective and safe on patients with angina pectoris.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect and safety of little dose defibrinogenase on patients with angina pectoris. Methods Forty cases received the little dose deribrinogenase by intravenous drips, other forty-six cases were control group. In order to judge the efficacy and safety of defibrinogenase, angina pectoris, ECG, live function, renal function and coagulation were observed in two groups. Results The total effective rate in treatment group was 82.50%, but in control group was 63.04%, there was significantly different (P0.01), and it had no side effect on live and renal function. Conclusions Little dose defibrinogenase is effective and safe on patients with angina pectoris.
Key concepts: Medicine, Angina, Renal function, Internal medicine, Cardiology, Myocardial infarction